Partnership Grants

The Leukaemia Foundation’s Partnership Grants are a strategic funding mechanism designed to accelerate progress in blood cancer research through co-investment and collaboration. These grants fund research that addresses critical gaps in knowledge, care, and outcomes for people living with blood cancer, particularly in complex or underfunded areas where coordinated effort is essential.

These grants aim to:

• Enable large-scale, high-impact research through co-investment
• Build and strengthen partnerships between the Leukaemia Foundation, research institutions, and funding bodies to address shared priorities in blood cancer.
• Foster genuine collaborations across institutions and disciplines bringing together complementary expertise to tackle complex challenges
• Coordinate investment and reduce duplication across the blood cancer research ecosystem by aligning efforts toward areas of unmet need
• Ensure research is aligned with patient and lived-experience priorities
• Accelerate the translation and uptake of research outcomes by supporting coordinated, partnership-driven approaches to implementation 

Partnership Grant details

Funding:

• Up to $100,000 over 2 years
• Leukaemia Foundation will contribute up to 50% of the total project cost, with the final funding contribution determined based on project scope, scale, and partner contributions.

Project focus:

Projects may focus on a specific blood cancer type or address multiple conditions and may target any stage of the patient journey – from diagnosis and active treatment through to survivorship and ongoing care. Multidisciplinary and cross-sector approaches are encouraged, recognising the complexity of blood cancer care and the need for solutions that are clinically relevant and patient-centred.

Examples can include:

• Collaboration on larger scale MRFF or NHMRC project applications with in-kind and financial support from the Leukaemia Foundation
• Implementation of survivorship and supportive care programs for people living with blood cancer
• Priority population equity initiatives focussed on improving barriers in accessing optimal care
• Digital health or data linkage projects that integrate hospital, pathology, and registry data to support real-world evidence generation and decision-making
• Improving diagnostic pathways, including integrated models between primary care, pathology, and specialist haematology services

Eligibility:

Projects must:

• Align with at least one of Leukaemia Foundation’s strategic research priorities
  • Implementation Science
  • Prevention, early detection, and diagnostics
  • Treatment and therapies
• Address a critical area of unmet need in blood cancer research, care, or patient outcomes
• Include at least one confirmed partner organisation also providing funding to the project and demonstrate where collaboration across institutions will provide benefit
• Demonstrate that the partnership between organisation(s) and the Leukaemia Foundation is essential in delivering the project
• Include meaningful consumer engagement appropriate to the project scope.

Lead applicants must:

• Hold academic, clinical or research appointment at an eligible institution (Australian university, hospital, health service, or research institution) with institutional support for the duration of the project 
• Demonstrate experience in, or clear capacity for, collaborative and/or multi-institutional research
• Provide evidence of a track record relative to opportunity, appropriate to the scale and scope of the proposed project
• Have the ability to secure ethics approval and comply with national research governance standards 
• Be able to commit sufficient time and oversight to lead the project for its duration.

Key dates:

• Applications open: 16 June 2026
• Applications close: 27 August 2026
• Applicants notified and project commencement: late September/early October 2026

How to apply

For further information on the Partnership Grants, please view the Partnership Grant guideline document below.

For any queries, please contact our research team via email at [email protected].